featured
news articles

Total number of categories

Total number of articles

Market/Novel Tech

Brexit decision is likely to have significant impact on drug development and IP protection.

The decision by the UK electorate on June 23rd to leave the European Union (EU) is likely to have a number of significant consequences for drug R&D and intellectual property (IP) protection within both academe and industry. Most notably, the European Medicines Agency (EMA), headquartered in London, may not continue to be located in the […]

Read full story
Featured

USPSTF expert panel recommends glucose screening for all overweight / obese 40-70 year olds.

A US expert panel (the U.S. Preventive Services Task Force, USPSTF) has recommended that it is cost-effective to screen overweight and obese adults between the ages of 40 and 70 years for abnormal glucose levels. The USPSTF is an independent, volunteer panel of national experts in prevention and evidence-based medicine. The Task Force works to […]

Read full story
Research

Researchers demonstrate potential benefit from targeting phospholipase A2 in model of diabetic macular edema (DME)

Research, led by the Centre for Experimental Medicine, Queen’s University Belfast, has shown that inhibition of lipoprotein-associated phospholipase A2 (Lp-PLA2) with darapladib, an experimental GSK atherosclerosis drug, may be capable of preventing diabetes-mediated blood-retinal barrier dysfunction. The pre-clinical research study also demonstrated that lysophosphatidylcholine (LPC), the substrate for Lp-PLA2, appears to impact on the retinal […]

Read full story
Introduction

July 6th, 2016: “EURETINA-Brief”© Issue No. 136

by Dr. Gearóid Tuohy   Dear EURETINA Members,   A very warm welcome to the July 6th, 2016 edition of EURETINA’s web-based digital magazine, “EURETINA Brief”. EURETINA are delighted to continue our delivery of up-to-date summary briefs on a range of topics of interest to retinal clinicians, specialists and researchers across Europe. This resource is […]

Read full story
Featured

Findings from an international genomics consortium almost double the number of associated genetic loci and variants for AMD

Research conducted by the International AMD Genomics Consortium (IAMDGC) has recently reported an almost doubling in the number of genetic risk loci associated with age-related macular degeneration (AMD). In a significant publication in the journal Nature Genetics, the research group has reported on an analysis of >12 million gene variants, “including 163,714 directly genotyped, mostly […]

Read full story
Introduction

January 18th, 2016: “EURETINA-Brief”© Issue No. 125

by Dr. Gearóid Tuohy   Dear EURETINA Members,   A very warm welcome to the January 18th, 2016 edition of EURETINA’s web-based digital magazine, “EURETINA Brief”. EURETINA are delighted to continue our delivery of up-to-date summary briefs on a range of topics of interest to retinal clinicians, specialists and researchers across Europe. This resource is […]

Read full story

Latest News

Book Review